100+ datasets found
  1. Cancer: 5-year survival rates in the U.S. by ethnic group 1975-2020

    • statista.com
    Updated Feb 18, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Cancer: 5-year survival rates in the U.S. by ethnic group 1975-2020 [Dataset]. https://www.statista.com/statistics/268518/5-year-cancer-survival-rate-in-the-us-by-ethnic-group/
    Explore at:
    Dataset updated
    Feb 18, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    In the period 2014-2020, around 69 percent of cancer patients surveyed between 2014 and 2020 from all ethnic groups survived a period of at least 5 years after diagnosis. This statistic shows the 5-year relative cancer survival rates in the U.S., by ethnic group, in periods between 1975 and 2020.

  2. Deaths by cancer in the U.S. 1950-2023

    • statista.com
    Updated Jun 24, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Deaths by cancer in the U.S. 1950-2023 [Dataset]. https://www.statista.com/statistics/184566/deaths-by-cancer-in-the-us-since-1950/
    Explore at:
    Dataset updated
    Jun 24, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    Cancer was responsible for around *** deaths per 100,000 population in the United States in 2023. The death rate for cancer has steadily decreased since the 1990’s, but cancer still remains the second leading cause of death in the United States. The deadliest type of cancer for both men and women is cancer of the lung and bronchus which will account for an estimated ****** deaths among men alone in 2025. Probability of surviving Survival rates for cancer vary significantly depending on the type of cancer. The cancers with the highest rates of survival include cancers of the thyroid, prostate, and testis, with five-year survival rates as high as ** percent for thyroid cancer. The cancers with the lowest five-year survival rates include cancers of the pancreas, liver, and esophagus. Risk factors It is difficult to determine why one person develops cancer while another does not, but certain risk factors have been shown to increase a person’s chance of developing cancer. For example, cigarette smoking has been proven to increase the risk of developing various cancers. In fact, around ** percent of cancers of the lung, bronchus and trachea among adults aged 30 years and older can be attributed to cigarette smoking. Other modifiable risk factors for cancer include being obese, drinking alcohol, and sun exposure.

  3. US Mortality Rates for All Types of Cancer

    • johnsnowlabs.com
    csv
    Updated Jan 20, 2021
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    John Snow Labs (2021). US Mortality Rates for All Types of Cancer [Dataset]. https://www.johnsnowlabs.com/marketplace/us-mortality-rates-for-all-types-of-cancer/
    Explore at:
    csvAvailable download formats
    Dataset updated
    Jan 20, 2021
    Dataset authored and provided by
    John Snow Labs
    Time period covered
    2010 - 2015
    Area covered
    United States
    Description

    Cancer survival statistics are typically expressed as the proportion of patients alive at some point subsequent to the diagnosis of their cancer. Statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer.

  4. Cancer death rates in the U.S. in 2022, by state

    • ai-chatbox.pro
    • statista.com
    Updated Sep 16, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    John Elflein (2024). Cancer death rates in the U.S. in 2022, by state [Dataset]. https://www.ai-chatbox.pro/?_=%2Ftopics%2F8656%2Fhealth-of-us-states%2F%23XgboD02vawLZsmJjSPEePEUG%2FVFd%2Bik%3D
    Explore at:
    Dataset updated
    Sep 16, 2024
    Dataset provided by
    Statistahttp://statista.com/
    Authors
    John Elflein
    Area covered
    United States
    Description

    In 2022, Utah had the lowest death rate from cancer among all U.S. states with around 116 deaths per 100,000 population. The states with the highest cancer death rates at that time were Mississippi, Kentucky and West Virginia. This statistic shows cancer death rates in the United States in 2022, by state.

  5. c

    Prostate Cancer Relative Survival Rates in U.S. by Age and Years...

    • consumershield.com
    csv
    Updated Apr 7, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    ConsumerShield Research Team (2025). Prostate Cancer Relative Survival Rates in U.S. by Age and Years Post-Diagnosis [Dataset]. https://www.consumershield.com/articles/prostate-cancer-survival-rate-by-age
    Explore at:
    csvAvailable download formats
    Dataset updated
    Apr 7, 2025
    Dataset authored and provided by
    ConsumerShield Research Team
    License

    Attribution-ShareAlike 4.0 (CC BY-SA 4.0)https://creativecommons.org/licenses/by-sa/4.0/
    License information was derived automatically

    Area covered
    United States of America
    Description

    The graph presents prostate cancer relative survival rates in the U.S. from 2001 to 2016, showing 1-year, 5-year, and 10-year relative survival percentages based on age groups. The x-axis represents age groups, while the y-axis indicates survival rates at different time intervals. Survival rates remain high across all age groups, with patients aged 65–69 having the highest 10-year survival rate of 99.5%. In contrast, men aged 80 and older have the lowest survival rates, with 92.1% at 1 year and 82.7% at 10 years. The data highlights that younger patients generally experience better long-term survival outcomes.

  6. Cancer: 5-year survival rates in the U.S. 2014-2020

    • statista.com
    Updated Jun 25, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Cancer: 5-year survival rates in the U.S. 2014-2020 [Dataset]. https://www.statista.com/statistics/268516/5-year-cancer-survival-rates-in-the-us/
    Explore at:
    Dataset updated
    Jun 25, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    In the period 2014-2020, approximately ** percent of liver cancer patients in the United States survived a period of at least 5 years after diagnosis. This statistic shows the 5-year relative cancer survival rates in the United States for the period 2014-2020, by type of cancer.

  7. CDC WONDER: Cancer Statistics

    • catalog.data.gov
    • healthdata.gov
    • +5more
    Updated Feb 22, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Centers for Disease Control and Prevention, Department of Health & Human Services (2025). CDC WONDER: Cancer Statistics [Dataset]. https://catalog.data.gov/dataset/cdc-wonder-cancer-statistics
    Explore at:
    Dataset updated
    Feb 22, 2025
    Description

    The United States Cancer Statistics (USCS) online databases in WONDER provide cancer incidence and mortality data for the United States for the years since 1999, by year, state and metropolitan areas (MSA), age group, race, ethnicity, sex, childhood cancer classifications and cancer site. Report case counts, deaths, crude and age-adjusted incidence and death rates, and 95% confidence intervals for rates. The USCS data are the official federal statistics on cancer incidence from registries having high-quality data and cancer mortality statistics for 50 states and the District of Columbia. USCS are produced by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI), in collaboration with the North American Association of Central Cancer Registries (NAACCR). Mortality data are provided by the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Vital Statistics System (NVSS).

  8. Deaths from breast cancer in the U.S. 1950-2022

    • statista.com
    • ai-chatbox.pro
    Updated Sep 20, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2024). Deaths from breast cancer in the U.S. 1950-2022 [Dataset]. https://www.statista.com/statistics/184615/deaths-by-breast-cancer-in-the-us-since-1950/
    Explore at:
    Dataset updated
    Sep 20, 2024
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    The rate of breast cancer deaths in the U.S. has dramatically declined since 1950. As of 2022, the death rate from breast cancer had dropped from 31.9 to 18.7 per 100,000 population. Cancer is a serious public health issue in the United States. As of 2021, cancer is the second leading cause of death among women. Breast cancer incidence Breast cancer symptoms include lumps or thickening of the breast tissue and may include changes to the skin. Breast cancer is driven by many factors, but age is a known risk factor. Among all age groups, the highest number of invasive breast cancer cases were among those aged 60 to 69. The incidence rate of new breast cancer cases is higher in some ethnicities than others. White, non-Hispanic women had the highest incidence rate of breast cancer, followed by non-Hispanic Black women. Breast cancer treatment Breast cancer treatments usually involve several methods, including surgery, chemotherapy and biological therapy. Types of cancer diagnosed at earlier stages often require fewer treatments. A majority of the early stage breast cancer cases in the U.S. receive breast conserving surgery and radiation therapy.

  9. M

    Breast Cancer Statistics 2025 By Types, Risks, Ratio

    • media.market.us
    Updated Jan 13, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Market.us Media (2025). Breast Cancer Statistics 2025 By Types, Risks, Ratio [Dataset]. https://media.market.us/breast-cancer-statistics/
    Explore at:
    Dataset updated
    Jan 13, 2025
    Dataset authored and provided by
    Market.us Media
    License

    https://media.market.us/privacy-policyhttps://media.market.us/privacy-policy

    Time period covered
    2022 - 2032
    Area covered
    Global
    Description

    Editor’s Choice

    • Global Breast Cancer Market size is expected to be worth around USD 49.2 Bn by 2032 from USD 19.8 Bn in 2022, growing at a CAGR of 9.8% during the forecast period from 2022 to 2032.
    • Breast cancer is the most common cancer among women worldwide. In 2020, there were about 2.3 million new cases of breast cancer diagnosed globally.
    • Breast cancer is the leading cause of cancer-related deaths in women. In 2020, it was responsible for approximately 685,000 deaths worldwide.
    • The survival rate of breast cancer has improved over the years. In the United States, the overall five-year survival rate of breast cancer is around 90%.
    • The American Cancer Society recommends annual mammograms starting at age 40 for women at average risk.
    • Although rare, breast cancer also occurs in men. Less than 1% of breast cancer cases are diagnosed in males.

    (Source: WHO, American Cancer Society)

    https://market.us/wp-content/uploads/2023/04/Breast-Cancer-Market-Value.jpg" alt="">

  10. f

    On the Validity of Using Increases in 5-Year Survival Rates to Measure...

    • plos.figshare.com
    bmp
    Updated Jun 4, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Yosef E. Maruvka; Min Tang; Franziska Michor (2023). On the Validity of Using Increases in 5-Year Survival Rates to Measure Success in the Fight against Cancer [Dataset]. http://doi.org/10.1371/journal.pone.0083100
    Explore at:
    bmpAvailable download formats
    Dataset updated
    Jun 4, 2023
    Dataset provided by
    PLOS ONE
    Authors
    Yosef E. Maruvka; Min Tang; Franziska Michor
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    BackgroundThe 5-year survival rate of cancer patients is the most commonly used statistic to reflect improvements in the war against cancer. This idea, however, was refuted based on an analysis showing that changes in 5-year survival over time bear no relationship with changes in cancer mortality.MethodsHere we show that progress in the fight against cancer can be evaluated by analyzing the association between 5-year survival rates and mortality rates normalized by the incidence (mortality over incidence, MOI). Changes in mortality rates are caused by improved clinical management as well as changing incidence rates, and since the latter can mask the effects of the former, it can also mask the correlation between survival and mortality rates. However, MOI is a more robust quantity and reflects improvements in cancer outcomes by overcoming the masking effect of changing incidence rates. Using population-based statistics for the US and the European Nordic countries, we determined the association of changes in 5-year survival rates and MOI.ResultsWe observed a strong correlation between changes in 5-year survival rates of cancer patients and changes in the MOI for all the countries tested. This finding demonstrates that there is no reason to assume that the improvements in 5-year survival rates are artificial. We obtained consistent results when examining the subset of cancer types whose incidence did not increase, suggesting that over-diagnosis does not obscure the results.ConclusionsWe have demonstrated, via the negative correlation between changes in 5-year survival rates and changes in MOI, that increases in 5-year survival rates reflect real improvements over time made in the clinical management of cancer. Furthermore, we found that increases in 5-year survival rates are not predominantly artificial byproducts of lead-time bias, as implied in the literature. The survival measure alone can therefore be used for a rough approximation of the amount of progress in the clinical management of cancer, but should ideally be used with other measures.

  11. H

    SEER Cancer Statistics Database

    • data.niaid.nih.gov
    • dataverse.harvard.edu
    Updated Jul 11, 2011
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    (2011). SEER Cancer Statistics Database [Dataset]. http://doi.org/10.7910/DVN/C9KBBC
    Explore at:
    Dataset updated
    Jul 11, 2011
    License

    CC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
    License information was derived automatically

    Description

    Users can access data about cancer statistics in the United States including but not limited to searches by type of cancer and race, sex, ethnicity, age at diagnosis, and age at death. Background Surveillance Epidemiology and End Results (SEER) database’s mission is to provide information on cancer statistics to help reduce the burden of disease in the U.S. population. The SEER database is a project to the National Cancer Institute. The SEER database collects information on incidence, prevalence, and survival from specific geographic areas representing 28 percent of the United States population. User functionality Users can access a variety of reso urces. Cancer Stat Fact Sheets allow users to look at summaries of statistics by major cancer type. Cancer Statistic Reviews are available from 1975-2008 in table format. Users are also able to build their own tables and graphs using Fast Stats. The Cancer Query system provides more flexibility and a larger set of cancer statistics than F ast Stats but requires more input from the user. State Cancer Profiles include dynamic maps and graphs enabling the investigation of cancer trends at the county, state, and national levels. SEER research data files and SEER*Stat software are available to download through your Internet connection (SEER*Stat’s client-server mode) or via discs shipped directly to you. A signed data agreement form is required to access the SEER data Data Notes Data is available in different formats depending on which type of data is accessed. Some data is available in table, PDF, and html formats. Detailed information about the data is available under “Data Documentation and Variable Recodes”.

  12. d

    Cancer Incidence - Surveillance, Epidemiology, and End Results (SEER)...

    • datasets.ai
    • healthdata.gov
    • +2more
    21
    Updated Sep 9, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    U.S. Department of Health & Human Services (2024). Cancer Incidence - Surveillance, Epidemiology, and End Results (SEER) Registries Limited-Use [Dataset]. https://datasets.ai/datasets/cancer-incidence-surveillance-epidemiology-and-end-results-seer-registries-limited-use
    Explore at:
    21Available download formats
    Dataset updated
    Sep 9, 2024
    Dataset authored and provided by
    U.S. Department of Health & Human Services
    Description

    SEER Limited-Use cancer incidence data with associated population data. Geographic areas available are county and SEER registry. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute collects and distributes high quality, comprehensive cancer data from a number of population-based cancer registries. Data include patient demographics, primary tumor site, morphology, stage at diagnosis, first course of treatment, and follow-up for vital status. The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and survival rates within each stage.

  13. f

    Global Blood Cancer Survival Rates: India vs The World

    • figshare.com
    pdf
    Updated Jun 6, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Divyansh Agarwal (2025). Global Blood Cancer Survival Rates: India vs The World [Dataset]. http://doi.org/10.6084/m9.figshare.29255054.v1
    Explore at:
    pdfAvailable download formats
    Dataset updated
    Jun 6, 2025
    Dataset provided by
    figshare
    Authors
    Divyansh Agarwal
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    World
    Description

    Blood cancer survival rates vary widely across the globe — and the contrast between India and developed nations is both eye-opening and urgent. While countries like the U.S., UK, and Germany report survival rates of 60–75% for common blood cancers such as leukaemia, lymphoma, and myeloma, India’s figures remain significantly lower, often ranging between 30 and 40%.This gap is driven by several critical factors: late diagnosis, limited access to advanced treatments, lack of awareness, and uneven healthcare infrastructure. Yet, with timely detection and modern therapies like CAR T-cell therapy and bone marrow transplant, these numbers can improve — and lives can be saved.At bmtnext.com, BMT NEXT is working to close this survival gap by offering world-class care, cutting-edge treatment options, and personalised support for every patient. Our mission is to ensure that patients in India receive the same level of care and hope as those in the most advanced healthcare systems.It’s time to bridge the divide — and BMT NEXT is leading the way.

  14. f

    Regional, racial, gender, and tumor biology disparities in breast cancer...

    • figshare.com
    docx
    Updated Jun 1, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Paddy Ssentongo; Joseph A. Lewcun; Xavier Candela; Anna E. Ssentongo; Eustina G. Kwon; Djibril M. Ba; John S. Oh; Forster Amponsah-Manu; Alicia C. McDonald; Vernon M. Chinchilli; David I. Soybel; Daleela G. Dodge (2023). Regional, racial, gender, and tumor biology disparities in breast cancer survival rates in Africa: A systematic review and meta-analysis [Dataset]. http://doi.org/10.1371/journal.pone.0225039
    Explore at:
    docxAvailable download formats
    Dataset updated
    Jun 1, 2023
    Dataset provided by
    PLOS ONE
    Authors
    Paddy Ssentongo; Joseph A. Lewcun; Xavier Candela; Anna E. Ssentongo; Eustina G. Kwon; Djibril M. Ba; John S. Oh; Forster Amponsah-Manu; Alicia C. McDonald; Vernon M. Chinchilli; David I. Soybel; Daleela G. Dodge
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    BackgroundThe survival rates from breast cancer in Africa are poor and yet the incidence rates are on the rise. In this study, we hypothesized that, in Africa, a continent with great disparities in socio-economic status, race, tumor biology, and cultural characteristics, the survival rates from breast cancer vary greatly based on region, tumor biology (hormone receptor), gender, and race. We aimed to conduct the first comprehensive systematic review and meta-analysis on region, gender, tumor-biology and race-specific 5-year breast cancer survival rates in Africa and compared them to 20-year survival trends in the United States.MethodsWe searched MEDLINE, EMBASE, and Cochrane Library to identify studies on breast cancer survival in African published before October 17, 2018. Pooled 5-year survival rates of breast cancer were estimated by random-effects models. We explored sources of heterogeneity through subgroup meta-analyses and meta-regression. Results were reported as absolute difference (AD) in percentages. We compared the survival rates of breast cancer in Africa and the United States.FindingsThere were 54 studies included, consisting of 18,970 breast cancer cases. There was substantial heterogeneity in the survival rates (mean 52.9%, range 7–91%, I2 = 99.1%; p for heterogeneity

  15. Cancer Surveillance and Epidemiology in the United States and Puerto Rico,...

    • icpsr.umich.edu
    ascii
    Updated Feb 11, 1993
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    National Cancer Institute (U.S.) (1993). Cancer Surveillance and Epidemiology in the United States and Puerto Rico, 1973-1977 [Dataset]. http://doi.org/10.3886/ICPSR08001.v2
    Explore at:
    asciiAvailable download formats
    Dataset updated
    Feb 11, 1993
    Dataset provided by
    Inter-university Consortium for Political and Social Researchhttps://www.icpsr.umich.edu/web/pages/
    Authors
    National Cancer Institute (U.S.)
    License

    https://www.icpsr.umich.edu/web/ICPSR/studies/8001/termshttps://www.icpsr.umich.edu/web/ICPSR/studies/8001/terms

    Time period covered
    1973 - 1977
    Area covered
    Puerto Rico, United States
    Description

    This dataset was produced as part of the Surveillance, Epidemiology, and End Results (SEER) Program to monitor the incidence of cancer and cancer survival rates in the United States, thus carrying out the mandates of the National Cancer Act. The SEER Program had several objectives: to estimate the annual cancer incidence in the United States, to examine trends in cancer patient survival, to identify cancer etiologic factors, and to monitor trends in the incidence of cancer in selected geographic areas with respect to demographic and social characteristics. Data collection began in 1973, and by 1977 had a population base of 11 geographic areas in the United States and Puerto Rico. SEER variables include patient demographic information (age, sex, race, birthplace, marital status, census tract) and information on cancer, which was gathered from hospitals, clinics, private laboratories, private practitioners, nursing/convalescent homes, autopsies, and death certificates. The medical data cover histologic type, anatomic site, laterality, multiplicity within primary site at first diagnosis, diagnostic procedures, diagnostic confirmation, sequence of the tumor, extent of the disease, treatment of the lesion, and outcome.

  16. 5-year survival rate for liver cancer as of 2020, by race and ethnicity

    • ai-chatbox.pro
    • statista.com
    Updated Jul 9, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2024). 5-year survival rate for liver cancer as of 2020, by race and ethnicity [Dataset]. https://www.ai-chatbox.pro/?_=%2Fstatistics%2F951902%2Fliver-cancer-5-year-survival-rates-us-by-ethnicity%2F%23XgboDwS6a1rKoGJjSPEePEUG%2FVFd%2Bik%3D
    Explore at:
    Dataset updated
    Jul 9, 2024
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    According to the data, 20.4 percent of non-Hispanic whites in the United States survived liver cancer five years after diagnosis. This statistic depicts the percentage of liver cancer patients who survive five years after diagnosis as of 2020, by race and ethnicity.

  17. d

    Percent Receiving Breast Cancer Screenings

    • data.ore.dc.gov
    Updated Aug 28, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    City of Washington, DC (2024). Percent Receiving Breast Cancer Screenings [Dataset]. https://data.ore.dc.gov/datasets/percent-receiving-breast-cancer-screenings
    Explore at:
    Dataset updated
    Aug 28, 2024
    Dataset authored and provided by
    City of Washington, DC
    License

    CC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
    License information was derived automatically

    Description

    Some racial and ethnic categories are suppressed for privacy and to avoid misleading estimates when the relative standard error exceeds 30% or the unweighted sample size is less than 50 respondents.

    Data Source: Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey (BRFSS) Data

    Why This Matters

    Breast cancer is the most commonly diagnosed cancer in women and people assigned female at birth (AFAB) and the second leading cause of cancer death in the U.S. Breast cancer screenings can save lives by helping to detect breast cancer in its early stages when treatment is more effective.

    While non-Hispanic white women and AFAB individuals are more likely to be diagnosed with breast cancer than their counterparts of other races and ethnicities, non-Hispanic Black women and AFAB individuals die from breast cancer at a significantly higher rate than their counterparts races and ethnicities.

    Later-stage diagnoses and prolonged treatment duration partly explain these disparities in mortality rate. Structural barriers to quality health care, insurance, education, affordable housing, and sustainable income that disproportionately affect communities of color also drive racial inequities in breast cancer screenings and mortality.

    The District Response

    Project Women Into Staying Healthy (WISH) provides free breast and cervical cancer screenings to uninsured or underinsured women and AFAB adults aged 21 to 64. Patient navigation, transportation assistance, and cancer education are also provided.

    DC Health’s Cancer and Chronic Disease Prevention Bureau works with healthcare providers to improve the use of preventative health services and provide breast cancer screening services.

    DC Health maintains the District of Columbia Cancer Registry (DCCR) to track cancer incidences, examine environmental substances that cause cancer, and identify differences in cancer incidences by age, gender, race, and geographical location.

  18. Rate of ovary cancer deaths in U.S. 1999-2021

    • ai-chatbox.pro
    • statista.com
    Updated Sep 4, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2024). Rate of ovary cancer deaths in U.S. 1999-2021 [Dataset]. https://www.ai-chatbox.pro/?_=%2Fstatistics%2F534726%2Fovary-cancer-death-rate-in-us%2F%23XgboD02vawLZsmJjSPEePEUG%2FVFd%2Bik%3D
    Explore at:
    Dataset updated
    Sep 4, 2024
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    1999 - 2021
    Area covered
    United States
    Description

    This statistic shows the death rate of ovary cancer per 100,000 age-adjusted population in the United States from 1999 to 2021. The maximum death rate in the given period for ovary cancer stood at nine in 2001 and 2002.

  19. p

    Cancer Treatment Centers in United States - 8,955 Verified Listings Database...

    • poidata.io
    csv, excel, json
    Updated Jun 13, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Poidata.io (2025). Cancer Treatment Centers in United States - 8,955 Verified Listings Database [Dataset]. https://www.poidata.io/report/cancer-treatment-center/united-states
    Explore at:
    csv, json, excelAvailable download formats
    Dataset updated
    Jun 13, 2025
    Dataset provided by
    Poidata.io
    Area covered
    United States
    Description

    Comprehensive dataset of 8,955 Cancer treatment centers in United States as of June, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

  20. f

    Time to initial cancer treatment in the United States and association with...

    • plos.figshare.com
    docx
    Updated Jun 4, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Alok A. Khorana; Katherine Tullio; Paul Elson; Nathan A. Pennell; Stephen R. Grobmyer; Matthew F. Kalady; Daniel Raymond; Jame Abraham; Eric A. Klein; R. Matthew Walsh; Emily E. Monteleone; Wei Wei; Brian Hobbs; Brian J. Bolwell (2023). Time to initial cancer treatment in the United States and association with survival over time: An observational study [Dataset]. http://doi.org/10.1371/journal.pone.0213209
    Explore at:
    docxAvailable download formats
    Dataset updated
    Jun 4, 2023
    Dataset provided by
    PLOS ONE
    Authors
    Alok A. Khorana; Katherine Tullio; Paul Elson; Nathan A. Pennell; Stephen R. Grobmyer; Matthew F. Kalady; Daniel Raymond; Jame Abraham; Eric A. Klein; R. Matthew Walsh; Emily E. Monteleone; Wei Wei; Brian Hobbs; Brian J. Bolwell
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    United States
    Description

    BackgroundDelays in time to treatment initiation (TTI) for new cancer diagnoses cause patient distress and may adversely affect outcomes. We investigated trends in TTI for common solid tumors treated with curative intent, determinants of increased TTI and association with overall survival.Methods and findingsWe utilized prospective data from the National Cancer Database for newly diagnosed United States patients with early-stage breast, prostate, lung, colorectal, renal and pancreas cancers from 2004–13. TTI was defined as days from diagnosis to first treatment (surgery, systemic or radiation therapy). Negative binomial regression and Cox proportional hazard models were used for analysis. The study population of 3,672,561 patients included breast (N = 1,368,024), prostate (N = 944,246), colorectal (N = 662,094), non-small cell lung (N = 363,863), renal (N = 262,915) and pancreas (N = 71,419) cancers. Median TTI increased from 21 to 29 days (P

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
Statista (2025). Cancer: 5-year survival rates in the U.S. by ethnic group 1975-2020 [Dataset]. https://www.statista.com/statistics/268518/5-year-cancer-survival-rate-in-the-us-by-ethnic-group/
Organization logo

Cancer: 5-year survival rates in the U.S. by ethnic group 1975-2020

Explore at:
Dataset updated
Feb 18, 2025
Dataset authored and provided by
Statistahttp://statista.com/
Area covered
United States
Description

In the period 2014-2020, around 69 percent of cancer patients surveyed between 2014 and 2020 from all ethnic groups survived a period of at least 5 years after diagnosis. This statistic shows the 5-year relative cancer survival rates in the U.S., by ethnic group, in periods between 1975 and 2020.

Search
Clear search
Close search
Google apps
Main menu